30 min listen
Efficacy of Therapeutic-Dose Heparin for Thromboprophylaxis in Hospitalized Patients With COVID-19
Efficacy of Therapeutic-Dose Heparin for Thromboprophylaxis in Hospitalized Patients With COVID-19
ratings:
Length:
17 minutes
Released:
Oct 7, 2021
Format:
Podcast episode
Description
Interview with Alex C. Spyropoulos, author of Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial
Released:
Oct 7, 2021
Format:
Podcast episode
Titles in the series (100)
Coronavirus Disease 2019 (COVID-19) Mitigation: Preparing Hospitals and Health Systems: The strategy for managing the COVID-19 pandemic has shifted from containment to mitigation. What does that mean for US hospitals and health systems? Kaiser Permanente Executive Vice President Stephen M. Parodi, MD, discusses telemedicine, protecting... by Coronavirus (COVID-19) Q&A